Development of a vaccine against COVID-19 based on recombinant BCG expressing SARS-Cov-2 antigenic determinants
- Funded by FAPESC Brazil
- Total publications:3 publications
Grant number: 401209/2020-2
Grant search
Key facts
Disease
COVID-19Funder
FAPESC BrazilPrincipal Investigator
N/A
Research Location
BrazilLead Research Institution
UFSC - Universidade Federal de Santa CatarinaResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC